The role of SPECT/CT in radioembolization of liver tumours
- 18 January 2014
- journal article
- review article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 41 (S1) , 115-124
Abstract
Radioembolization (RE) with 90Y microspheres is a promising catheter-based therapeutic option for patients with unresectable primary and metastatic liver tumours. Its rationale arises from the dual blood supply of liver tissue through the hepatic artery and the portal vein. Metastatic hepatic tumours measuring >3 mm derive 80 – 100 % of their blood supply from the arterial rather than the portal hepatic circulation. Typically, an angiographic evaluation combined with 99mTc-macroaggregated albumin (99mTc-MAA) scan precedes therapy to map the tumour feeding vessels as well as to avoid the inadvertent deposition of microspheres in organs other than the liver. Prior to administration of 99mTc-MAA, prophylactic coil embolization of the gastroduodenal artery is recommended to avoid extrahepatic deposition of the microspheres. SPECT/CT allows direct correlation of anatomic and functional information in patients with unresectable liver disease. SPECT/CT is recommended to assess intrahepatic distribution as well as extrahepatic gastrointestinal uptake in these patients. Pretherapeutic SPECT/CT is an important component of treatment planning including catheter positioning and dose finding. A post-therapy bremsstrahlung (BS) scan should follow RE to verify the distribution of the administered tracer. BS SPECT/CT imaging enables better localization and definition of intrahepatic and possible extrahepatic sphere distribution and to a certain degree allows posttreatment dosimetry. In this paper we address the usefulness and significance of SPECT/CT in therapy planning and therapy monitoring of RE.Keywords
This publication has 77 references indexed in Scilit:
- Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising conceptEuropean Journal of Nuclear Medicine and Molecular Imaging, 2013
- Development and evaluation of an improved quantitative 90Y bremsstrahlung SPECT methodMedical Physics, 2012
- Usefulness and pitfalls of MAA SPECT/CT in identifying digestive extrahepatic uptake when planning liver radioembolizationEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- Hemoglobin level significantly impacts the tumor cell survival fraction in humans after internal radiotherapyEJNMMI Research, 2012
- Radioembolization Results in Longer Time-to-Progression and Reduced Toxicity Compared With Chemoembolization in Patients With Hepatocellular CarcinomaGastroenterology, 2011
- Yttrium-90-labeled microsphere tracking during liver selective internal radiotherapy by bremsstrahlung pinhole SPECT: feasibility study and evaluation in an abdominal phantomEJNMMI Research, 2011
- Technical Solutions to Ensure Safe Yttrium-90 Radioembolization in Patients With Initial Extrahepatic Deposition of 99mTechnetium–Albumin MacroaggregatesCardioVascular and Interventional Radiology, 2010
- Prophylactic Embolization of the Cystic Artery Before Radioembolization: Feasibility, Safety, and OutcomesCardioVascular and Interventional Radiology, 2010
- 90Y bremsstrahlung emission computed tomography using gamma camerasAnnals of Nuclear Medicine, 2009
- Clinical effects of transcatheter hepatic arterial embolization with holmium-166 poly(l-lactic acid) microspheres in healthy pigsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2008